Skip to Content
MDPIMDPI

Advanced

Current Oncology
Submit to Current Oncology

30th Anniversary

The year 2024 marks the 30th anniversary of Current Oncology, a peer-reviewed open access journal on clinical oncology. With an Impact Factor of 2.8 and a CiteScore of 3.3, the journal is covered in Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and other databases. The journal has published more than 3,800 papers from more than 17,200 authors, who are from 98 countries. More than 5,300 reviewers have reviewed the journal at least once. We value all contributions made by our editors, authors, and reviewers equally.

In honor of the journal’s 30th anniversary, we are reflecting on our past accomplishments and embarking on an exciting new chapter. We invite you to join us in celebrating this milestone for our journal and to explore the content we have prepared for you below.

30th Anniversary of <em>Current Oncology</em> Video

Journal History

The inaugural issue was released by Mutlimed Inc.

Current Oncology was published as a quarterly journal.

Celebration Activities

Key Figures

Testimonials

Top 10 Cited Papers

Anniversary Special Issues

News

1. Current Oncology | Affiliated Societies Collaboration

We are pleased to announce that we have established collaboration with the following 6 societies:

Canadian Association of General Practitioners in Oncology (CAGPO-ACMOO)

Canadian Association of Medical Oncologists (CAMO)

Canadian Association of Psychosocial Oncology (CAPO) - Association Canadienne d'Oncologie Psychosociale (ACOP)

Canadian Centre for Applied Research in Cancer Control (ARCC)

Canadian Leukemia Study Group (CLSG)

Cell Therapy Transplant Canada (CTTC)

As part of this collaboration, all members of the societies above will enjoy a discount on the Article Processing Charge (APC) when submitting articles to Current Oncology. The collaboration goes beyond the discount benefit offered to members and includes other services as well as cross-promotions.

Please visit the following link for more information: https://www.mdpi.com/journal/curroncol/societies

2. Welcoming the New Section Editors-in-Chief of Current Oncology

We are pleased to announce that Prof. Dr. Matthias May, Prof. Dr. Katrin Scheinemann, and Dr. Stuart Peacock have been appointed Editors-in-Chief of the Sections “Genitourinary Oncology”, “Childhood, Adolescent and Young Adult Oncology”, and “Health Economics”, respectively. We look forward to their contributions to Current Oncology (ISSN: 1718-7729).

Name: Prof. Dr. Matthias May

Affiliation: Department of Urology, St. Elisabeth Hospital Straubing, 94315 Straubing, Germany
Interests: bladder cancer; prostate cancer; renal cell carcinoma; robot-assisted surgery; biomarker-based oncology studies; prognostic outcome models; translational research, multicenter projects in genitourinary oncology research

Name: Prof. Dr. Katrin Scheinemann
Affiliation: Division of Hematology/Oncology, Children’s Hospital of Eastern Switzerland, 9006 St. Gallen, Switzerland
Interests: survivorship; long-term follow-up care; neurooncology; AYA oncology

Name: Prof. Dr. Stuart Peacock

Affiliation: 1. Leslie Diamond Chair in Cancer Survivorship, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
2. Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1L3, Canada
3. Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC V5Z 1L3, Canada
Interests: cancer survivorship; health economics; quality of life; priority setting; public engagement

Special Issue Collection

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729
Imprint
Download Flyer